Conditions: NSCLC; NSCLC, Stage I; NSCLC Stage II; Non Small Cell Lung Cancer; Non-small Cell Lung Cancer Stage I; Non-small Cell Lung Cancer Stage II; Interstitial Lung Disease; Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)
Interventions: Drug: BIO 300
Sponsors: Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**
Interventions: Drug: BIO 300
Sponsors: Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
